This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Next Generation CAR & T Cell Therapies

LAST CHANCE: REGISTER BY MAY 20 TO SAVE UP TO $300

  • 00
    Days
  • 00
    Hrs
  • 00
    Mins
  • 00
    Secs
June 14-16, 2022
Delivered as a Hybrid EventIntercontinental Mark Hopkins Hotel, San Francisco, California

Parameswaran Hari, MD
Senior Vice President of Clinical Science at Iovance Biotherapeutics, Inc., USA

Profile

Parameswaran Hari MD is the Senior VP of Clinical Science at Iovance Biotherapeutics. He came to industry after an academic career in bone marrow transplantation, cellular and gene modified therapies and plasma cell disorders. Prior to Iovance, he was Chief of Hematology Oncology at the Medical College of Wisconsin and led their stem cell transplant program since 2007. Hari has more than 400 peer reviewed publications and was a scientific director at the CIBMTR. His interests and passion are in expanding the scope of cellular therapies in solid tumors with adoptive T cell strategies.

Agenda Sessions

  • TIL Case Study

    4:45pm